医药前沿
醫藥前沿
의약전연
YIAYAO QIANYAN
2015年
23期
62-62,63
,共2页
显微结构%超微结构%糖尿病%肺部组织
顯微結構%超微結構%糖尿病%肺部組織
현미결구%초미결구%당뇨병%폐부조직
Microstructure%Ultrastructure%Lung tissue%Diabetes
目的:探讨糖尿病患者肺部组织病理特征,为临床研究提供参考。方法:选择行肺部肿块切除术的56例患者作为研究对象,分成两组,其中一组为糖尿病组,一组为非糖尿病组,各28例。观察两组肺部组织显微及超微结构,并分析转化生长因子(TGF-β1)及肺泡表面活性蛋白(SP-A)、晚期糖基化终末产物(AGEs)的差异。结果:糖尿病组患者在光镜下可见肺组织有胶原纤维增生,电镜下可见细胞质内,有线粒体基质溶解,及嵴大部分发生溶解,毛细血管内皮基底膜未见增厚,肺部组织SP-A表达要显著低于非糖尿病组患者,但TGF-β1与AGEs有增加,统计学差异明显(P<0.05)。结论:糖尿病患者肺部组织病理改变有其独特性,肺部是糖尿病损伤中的靶器官。
目的:探討糖尿病患者肺部組織病理特徵,為臨床研究提供參攷。方法:選擇行肺部腫塊切除術的56例患者作為研究對象,分成兩組,其中一組為糖尿病組,一組為非糖尿病組,各28例。觀察兩組肺部組織顯微及超微結構,併分析轉化生長因子(TGF-β1)及肺泡錶麵活性蛋白(SP-A)、晚期糖基化終末產物(AGEs)的差異。結果:糖尿病組患者在光鏡下可見肺組織有膠原纖維增生,電鏡下可見細胞質內,有線粒體基質溶解,及嵴大部分髮生溶解,毛細血管內皮基底膜未見增厚,肺部組織SP-A錶達要顯著低于非糖尿病組患者,但TGF-β1與AGEs有增加,統計學差異明顯(P<0.05)。結論:糖尿病患者肺部組織病理改變有其獨特性,肺部是糖尿病損傷中的靶器官。
목적:탐토당뇨병환자폐부조직병리특정,위림상연구제공삼고。방법:선택행폐부종괴절제술적56례환자작위연구대상,분성량조,기중일조위당뇨병조,일조위비당뇨병조,각28례。관찰량조폐부조직현미급초미결구,병분석전화생장인자(TGF-β1)급폐포표면활성단백(SP-A)、만기당기화종말산물(AGEs)적차이。결과:당뇨병조환자재광경하가견폐조직유효원섬유증생,전경하가견세포질내,유선립체기질용해,급척대부분발생용해,모세혈관내피기저막미견증후,폐부조직SP-A표체요현저저우비당뇨병조환자,단TGF-β1여AGEs유증가,통계학차이명현(P<0.05)。결론:당뇨병환자폐부조직병리개변유기독특성,폐부시당뇨병손상중적파기관。
Objective To explore the pathological features of lung tissue in patients with diabetes, to provide reference for clinical research. Method To Choose OK lung tumor resection 56 patients as research subjects, divided into two groups, one group for the diabetic group, a group of non-diabetic group, 28 cases each. Lung tissue were observed microscopic and ultrastructural, and analyze the difference of transforming growth factor (TGF-β1) and pulmonary surfactant proteins (SP-A), advanced glycation end products (AGEs) in. Result Diabetes patients can be seen in the light microscope has collagen fibers in lung tissue, electron microscope, the cytoplasm, mitochondria matrix dissolution, and the crest most dissolves, no capillary endothelial basement membrane thickening, SP-A expression in lung tissue To significantly lower than non-diabetic patients, but TGF-β1 and AGEs have increased statistically significantly different (P<0.05). Conclusion Pathological changes in the lungs of patients with diabetes is unique, diabetes, lung is a target organ injury.